Suppr超能文献

S1P(4)受体介导 S1P 诱导的正常血压和高血压大鼠肺血管收缩。

S1P(4) receptor mediates S1P-induced vasoconstriction in normotensive and hypertensive rat lungs.

机构信息

Department of Pharmacology and Internal Medicine, and Center for Lung Biology, University of South Alabama College of Medicine, Mobile, Alabama, USA.

出版信息

Pulm Circ. 2011 Jul-Sep;1(3):399-404. doi: 10.4103/2045-8932.87309.

Abstract

This study aimed to identify receptors mediating sphingosine-1-phosphate (S1P)-induced vasoconstriction in the normotensive and chronic hypoxia-induced hypertensive rat pulmonary circulation. In isolated perfused lungs from normoxic rats, infusion of S1P caused a sustained vasoconstriction, which was not reduced by combinational pretreatment with the dual S1P(1 and 3) receptor antagonist VPC23019 and the S1P(2) receptor antagonist JTE013. The S1P(4) receptor agonists phytosphingosine-1-phospate and VPC23153, but not the dual S1P(1 and 3) receptor agonist VPC24191, caused dose-dependent vasoconstrictions. In hypertensive lungs from chronically hypoxic rats, the vasoconstrictor responses to S1P and VPC23153 were markedly enhanced. The S1P(4) receptor agonist VPC 23153 caused contraction of isolated pulmonary but not of renal or mesenteric arteries from chronically hypoxic rats. S1P(4) receptor protein as well as mRNA were detected in both normotensive and hypertensive pulmonary arteries. In contrast to what has been reported in the systemic circulation and mouse lung, our findings raise the possibility that S1P(4) receptor plays a significant role in S1P-induced vasoconstriction in the normotensive and hypertensive rat pulmonary circulation.

摘要

本研究旨在鉴定介导鞘氨醇-1-磷酸(S1P)诱导的正常血压和慢性低氧诱导的高血压大鼠肺循环血管收缩的受体。在来自正常氧合大鼠的离体灌注肺中,S1P 的输注引起持续的血管收缩,联合预处理双重 S1P(1 和 3)受体拮抗剂 VPC23019 和 S1P(2)受体拮抗剂 JTE013 并不能减轻这种收缩。S1P(4)受体激动剂植物鞘氨醇-1-磷酸和 VPC23153 引起剂量依赖性的血管收缩,但双重 S1P(1 和 3)受体激动剂 VPC24191 则没有。在慢性低氧大鼠的高血压肺中,S1P 和 VPC23153 的血管收缩反应明显增强。S1P(4)受体激动剂 VPC 23153 引起慢性低氧大鼠离体肺血管收缩,但对肾或肠系膜动脉没有收缩作用。S1P(4)受体蛋白和 mRNA 均在正常血压和高血压肺血管中检测到。与在体循环和小鼠肺中报道的情况相反,我们的研究结果表明,S1P(4)受体在正常血压和高血压大鼠肺循环中 S1P 诱导的血管收缩中可能发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9765/3224432/d513c99a3aba/PC-1-399-g001.jpg

相似文献

1
S1P(4) receptor mediates S1P-induced vasoconstriction in normotensive and hypertensive rat lungs.
Pulm Circ. 2011 Jul-Sep;1(3):399-404. doi: 10.4103/2045-8932.87309.
3
EDRF suppresses an unidentified vasoconstrictor mechanism in hypertensive rat lungs.
Am J Physiol. 1993 Jun;264(6 Pt 1):L587-97. doi: 10.1152/ajplung.1993.264.6.L587.
5
Endothelin-1 mediates nitro-L-arginine vasoconstriction of hypertensive rat lungs.
Am J Physiol. 1997 May;272(5 Pt 1):L807-12. doi: 10.1152/ajplung.1997.272.5.L807.
7
Thapsigargin stimulates increased NO activity in hypoxic hypertensive rat lungs and pulmonary arteries.
J Appl Physiol (1985). 1996 Apr;80(4):1336-44. doi: 10.1152/jappl.1996.80.4.1336.
8
S1P2 receptor-dependent Rho-kinase activation mediates vasoconstriction in the murine pulmonary circulation induced by sphingosine 1-phosphate.
Am J Physiol Lung Cell Mol Physiol. 2010 Jul;299(1):L137-45. doi: 10.1152/ajplung.00233.2009. Epub 2010 Apr 30.
10
Different response patterns of several ligands at the sphingosine-1-phosphate receptor subtype 3 (S1P(3)).
Br J Pharmacol. 2009 Apr;156(8):1305-11. doi: 10.1111/j.1476-5381.2009.00134.x. Epub 2009 Mar 20.

引用本文的文献

1
Molecular heterogeneity in human stroke - What can we learn from the peripheral blood transcriptome?
J Cereb Blood Flow Metab. 2025 Mar 13:271678X251322598. doi: 10.1177/0271678X251322598.
2
Receptor-dependent effects of sphingosine-1-phosphate (S1P) in COVID-19: the black side of the moon.
Mol Cell Biochem. 2023 Oct;478(10):2271-2279. doi: 10.1007/s11010-023-04658-7. Epub 2023 Jan 18.
3
S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review.
Ther Adv Neurol Disord. 2022 Nov 22;15:17562864221133163. doi: 10.1177/17562864221133163. eCollection 2022.
4
Pathophysiology and pathogenic mechanisms of pulmonary hypertension: role of membrane receptors, ion channels, and Ca signaling.
Physiol Rev. 2023 Jul 1;103(3):1827-1897. doi: 10.1152/physrev.00030.2021. Epub 2022 Nov 24.
5
Autoimmunity to Sphingosine-1-Phosphate-Receptors in Systemic Sclerosis and Pulmonary Arterial Hypertension.
Front Immunol. 2022 Jul 4;13:935787. doi: 10.3389/fimmu.2022.935787. eCollection 2022.
7
Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.
Int J Mol Sci. 2020 Sep 29;21(19):7189. doi: 10.3390/ijms21197189.
8
Post-translational modifications of S1PR1 and endothelial barrier regulation.
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Sep;1865(9):158760. doi: 10.1016/j.bbalip.2020.158760. Epub 2020 Jun 22.
10
Pulmonary vascular dysfunction secondary to pulmonary arterial hypertension: insights gained through retrograde perfusion.
Am J Physiol Lung Cell Mol Physiol. 2018 May 1;314(5):L835-L845. doi: 10.1152/ajplung.00201.2017. Epub 2018 Jan 18.

本文引用的文献

2
S1P2 receptor-dependent Rho-kinase activation mediates vasoconstriction in the murine pulmonary circulation induced by sphingosine 1-phosphate.
Am J Physiol Lung Cell Mol Physiol. 2010 Jul;299(1):L137-45. doi: 10.1152/ajplung.00233.2009. Epub 2010 Apr 30.
3
S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.
Am J Physiol Cell Physiol. 2009 Aug;297(2):C451-8. doi: 10.1152/ajpcell.00586.2008. Epub 2009 May 27.
4
Regulation of vascular physiology and pathology by the S1P2 receptor subtype.
Cardiovasc Res. 2009 May 1;82(2):221-8. doi: 10.1093/cvr/cvp088. Epub 2009 Mar 15.
5
Sphingosine-1-phosphate and modulation of vascular tone.
Cardiovasc Res. 2009 May 1;82(2):212-20. doi: 10.1093/cvr/cvp064. Epub 2009 Feb 20.
6
Lysophospholipid receptors in vertebrate development, physiology, and pathology.
J Lipid Res. 2009 Apr;50 Suppl(Suppl):S293-8. doi: 10.1194/jlr.R800047-JLR200. Epub 2008 Dec 8.
7
Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling.
J Lipid Res. 2009 Apr;50 Suppl(Suppl):S272-6. doi: 10.1194/jlr.R800065-JLR200. Epub 2008 Nov 5.
8
Regulation of vascular permeability by sphingosine 1-phosphate.
Microvasc Res. 2009 Jan;77(1):39-45. doi: 10.1016/j.mvr.2008.09.005. Epub 2008 Sep 30.
9
Sphingolipids in the lungs.
Am J Respir Crit Care Med. 2008 Dec 1;178(11):1100-14. doi: 10.1164/rccm.200804-595SO. Epub 2008 Aug 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验